Zynerba Pharmaceuticals : Acquisition/Asset Disposal - Form 8-K -October 11, 2023 at 08:21 am EDT
Item 2.01. Completion of Acquisition or Disposition of Assets. On October 10, 2023, Harmony Biosciences...
Source: marketscreener.com
Second Indication News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Second Indication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Second Indication Today - Breaking & Trending Today
HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
PLYMOUTH MEETING, Pa. and DEVON, Pa., Aug. 14, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. , a pharmaceutical company dedicated to developing and commercializing innovative therapies... -Today at 07:31 am- MarketScreener
Source: marketscreener.com
BCG Vaccine News | Live Feed & Top Stories
Read the latest BCG Vaccine headlines - updated 24/7/365. We link to the best sources from around the world. Get the latest on the BCG Vaccine...
Source: newsnow.co.uk
Pharma Stock Roundup: JNJ's Q1 Earnings & Sales Beat, RHHBY Sales, & Other Updates
Pharma Stock Roundup: JNJ's Q1 Earnings & Sales Beat, RHHBY Sales, & Other Updates Zacks.com 2 hrs ago J&J JNJ announced strong first-quarter results, beating estimates for both earnings and sales. Roche’s RHHBY COVID-19 diagnostics tests sales boosted the top line, offsetting declines in its core drug business. The FDA granted approval to Glaxo’s GSK endometrial cancer therapy, Jemperli (dostarlimab). Recap of the Week’s Most Important Stories J&J Earnings & Sales Beat: J&J beat first-quarter estimates for earnings as well as sales. Its Pharmaceuticals unit continued to perform ab...
Source: msn.com